Yumiko Azuma

878 citations

33 papers · 487 indexed · h-index 14

Co-authors: Takahiko Tokuda Toshiki Mizuno Masamitsu Yamaguchi Masanori Nakagawa Ikuko Mizuta Hideki Yoshida Yoshitaka Nagai Hisafumi Yamada‐Okabe
Topics: Amyotrophic Lateral Sclerosis Research (9 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Neurogenetic and Muscular Disorders Research (6 papers)
Cited by: Neurology Genetics
Journals: Nature Communications PLoS ONE Cancer Research
Partner nations: Japan United States Qatar

In The Last Decade

Yumiko Azuma

33 papers receiving 476 citations

Peers

Countries citing papers authored by Yumiko Azuma

Since Specialization

Citations

This map shows the geographic impact of Yumiko Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumiko Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumiko Azuma more than expected).

Fields of papers citing papers by Yumiko Azuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumiko Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumiko Azuma. The network helps show where Yumiko Azuma may publish in the future.

Co-authorship network of co-authors of Yumiko Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Yumiko Azuma. A scholar is included among the top collaborators of Yumiko Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumiko Azuma. Yumiko Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs 2018 ·Experimental Neurology ·(unknown),Aya Nakamura,Ryo Tanaka,(unknown),Yumiko Azuma,(unknown),Luca Lo Piccolo,Hideki Yoshida,Ikuko Mizuta,Takahiko Tokuda,Toshiki Mizuno,Masanori Nakagawa,Masamitsu Yamaguchi	27
2	Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders 2018 ·Brain Research ·(unknown),Ryo Tanaka,(unknown),(unknown),Yumiko Azuma,Hideki Yoshida,Takahiko Tokuda,Satoshi Asada,(unknown),Kenji Ichiyanagi,Seiko Ohno,Masanobu Itoh,Masamitsu Yamaguchi	18
3	NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene 2018 ·Scientific Reports ·Itaru Yamamoto,Yumiko Azuma,(unknown),Hideki Yoshida,Ikuko Mizuta,Toshiki Mizuno,Morio Ueyama,Yoshitaka Nagai,Takahiko Tokuda,Masamitsu Yamaguchi	3
4	Amyotrophic Lateral Sclerosis Model 2018 ·Advances in experimental medicine and biology ·Yumiko Azuma,Ikuko Mizuta,Takahiko Tokuda,Toshiki Mizuno	10
5	Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46 2018 ·Brain Research ·(unknown),(unknown),Yumiko Azuma,(unknown),Hideki Yoshida,Masamitsu Yamaguchi	19
6	Loss-of-function mutation in Hippo suppressed enlargement of lysosomes and neurodegeneration caused by dFIG4 knockdown 2018 ·Neuroreport ·(unknown),Yumiko Azuma,Ikuko Mizuta,(unknown),(unknown),Hideki Yoshida,Takahiko Tokuda,Toshiki Mizuno,Masamitsu Yamaguchi	6
7	Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS 2018 ·Experimental Cell Research ·Yumiko Azuma,Takahiko Tokuda,(unknown),Itaru Yamamoto,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Morio Ueyama,Yoshitaka Nagai,Yasushi Iwasaki,Mari Yoshida,Duojia Pan,Hideki Yoshida,Masamitsu Yamaguchi	16
8	Abstract 5609: ERY974, a novel T cell-redirecting bispecific antibody targeting glypican-3, shows antitumor activity in gastric cancer patient-derived xenograft models with varying glypican-3 expression 2018 ·Cancer Research ·Yumiko Azuma,Yuji Sano,Toshiaki Tsunenari,Yasuko Kinoshita,Yoko Miyazaki,Junko Shinozuka,Etsuko Fujii,Atsuhiko Kato,Takahiro Ishiguro,Shohei Kishishita,Jun‐ichi Nezu,Yoshiki Kawabe,Mika Endo	2
9	Loss of function mutant of ter94, Drosophila VCP, partially enhanced motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43 2017 ·Journal of the Neurological Sciences ·(unknown),Takahiko Tokuda,Yumiko Azuma,Ikuo Yamamoto,Hideki Yoshida,Ikuko Mizuta,Morio Ueyama,Yoshitaka Nagai,M. Nakagawa,Toshiki Mizuno,Masamitsu Yamaguchi	1
10	Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism? 2017 ·npj Parkinson s Disease ·(unknown),Takashi Kasai,Ikuko Mizuta,(unknown),Shinya Osone,Yumiko Azuma,Toshihiko Imamura,Takahiko Tokuda,Hitoshi Kanno,Omar M. A. El‐Agnaf,Masafumi Morimoto,Masanori Nakagawa,Hajime Hosoi,Toshiki Mizuno	40
11	Knockdown of the Drosophila FIG4 induces deficient locomotive behavior, shortening of motor neuron, axonal targeting aberration, reduction of life span and defects in eye development 2015 ·Experimental Neurology ·(unknown),Yumiko Azuma,Itaru Yamamoto,Hideki Yoshida,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Takahiko Tokuda,Masamitsu Yamaguchi	30
12	Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway 2014 ·Experimental Cell Research ·(unknown),(unknown),Yumiko Azuma,Hideki Yoshida,Thanh Nguyen,Ikuko Mizuta,Tomokatsu Yoshida,Toshiki Mizuno,Masanori Nakagawa,Takahiko Tokuda,Masamitsu Yamaguchi	18
13	Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS 2014 ·Human Molecular Genetics ·Yumiko Azuma,Takahiko Tokuda,(unknown),(unknown),Hiroshi Sasayama,Tomokatsu Yoshida,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Nobuhiro Fujikake,Morio Ueyama,Yoshitaka Nagai,Masamitsu Yamaguchi	36
14	Sixty Six–Month Follow-up of Muscle Power and Respiratory Function in a Case With Adult-Type Pompe Disease Treated With Enzyme Replacement Therapy 2014 ·Journal of Clinical Neuromuscular Disease ·(unknown),Kensuke Shiga,(unknown),Yumiko Azuma,(unknown),(unknown),(unknown),Nagato Kuriyama,(unknown),Toshiki Mizuno,Masanori Nakagawa	5
15	Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches 2012 ·PLoS ONE ·Hiroshi Sasayama,(unknown),Takahiko Tokuda,Yumiko Azuma,Tomokatsu Yoshida,Toshiki Mizuno,Masanori Nakagawa,Nobuhiro Fujikake,Yoshitaka Nagai,Masamitsu Yamaguchi	61
16	Extraischemic cerebral hematomas of the cerebellum in an extremely elderly stroke patient treated with intravenous rt-PA therapy: A case report 2010 ·Nosotchu ·(unknown),Keisuke Imai,(unknown),Masahiro Makino,(unknown),Yumiko Azuma,Fumiko Oshima,Kenichiro Oda	1
17	A case report of HTLV-I associated myelopathy presenting with cerebellar ataxia and nystagmus 2010 ·Auris Nasus Larynx ·(unknown),Fumiaki Nin,(unknown),Hirofumi Sakaguchi,Toshihiro Suzuki,Yasuo Hisa,Yumiko Azuma,Masanori Nakagawa	3
18	Interferon‐α enhances CD317 expression and the antitumor activity of anti‐CD317 monoclonal antibody in renal cell carcinoma xenograft models 2008 ·Cancer Science ·Shigeto Kawai,Yumiko Azuma,Etsuko Fujii,(unknown),Shuji Ozaki,Toshio Matsumoto,Masaaki Kosaka,Hisafumi Yamada‐Okabe	39
19	Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia 2007 ·Oncology Reports ·(unknown),Yasuko Kinoshita,Yumiko Azuma,Toshiaki Tsunenari,Yasushi Yoshimura,Shinichiro Iida,Yasufumi Kikuchi,Hisafumi Yamada‐Okabe,Naoshi Fukushima	45
20	2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells 2004 ·Biochemical and Biophysical Research Communications ·Naoki Kimura,Shigeto Kawai,Yasuko Kinoshita,Takahiro Ishiguro,Yumiko Azuma,Shuji Ozaki,Masahiro Abe,Masamichi Sugimoto,Yuichi Hirata,Tetsuro Orita,Hisafumi Okabe,Toshio Matsumoto,Masayuki Tsuchiya	8

About Yumiko Azuma

Yumiko Azuma is a scholar working on Neurology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 487 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Neurogenetic and Muscular Disorders Research (6 papers). The work is most often cited by research in Neurology (173 citations), Genetics (84 citations) and Neurology (47 citations). Yumiko Azuma has collaborated with scholars based in Japan, United States and Qatar. Frequent co-authors include Takahiko Tokuda, Toshiki Mizuno, Masamitsu Yamaguchi, Masanori Nakagawa, Ikuko Mizuta, Hideki Yoshida, Yoshitaka Nagai, Hisafumi Yamada‐Okabe, Tomokatsu Yoshida and Nobuhiro Fujikake. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact